Progress towards a new tuberculosis vaccine (1998)
- Authors:
- Autor USP: SILVA, CELIO LOPES - FMRP
- Unidade: FMRP
- Subjects: VACINAS; TUBERCULOSE
- Language: Inglês
- Imprenta:
- Source:
-
ABNT
LOWRIE, Douglas B. e SILVA, Célio Lopes e TASCON, Ricardo E. Progress towards a new tuberculosis vaccine. BioDrugs, v. 10, n. 3, p. 201-213, 1998Tradução . . Acesso em: 05 out. 2024. -
APA
Lowrie, D. B., Silva, C. L., & Tascon, R. E. (1998). Progress towards a new tuberculosis vaccine. BioDrugs, 10( 3), 201-213. -
NLM
Lowrie DB, Silva CL, Tascon RE. Progress towards a new tuberculosis vaccine. BioDrugs. 1998 ; 10( 3): 201-213.[citado 2024 out. 05 ] -
Vancouver
Lowrie DB, Silva CL, Tascon RE. Progress towards a new tuberculosis vaccine. BioDrugs. 1998 ; 10( 3): 201-213.[citado 2024 out. 05 ] - Cell wall components of ac actinomycetis involved in the pathogeny of actinomicotic mycetona
- Cord factor is associated with the maintenance of chronic inflammatory reaction caused by mycobacteria
- Mouse toxicity induced by lipids and cell wall isolated from actinomycetis
- Granuloma formation in paracoccidiodomycosis is due the polyssacharide constituent of paracoccidiodes brasiliensis
- Tumor necrosis factor macrophage activation are important in clearance of nocardia brasiliensis from the livers and spleen of mice
- Inflammation induce by mycolic acid-containing glycolipidis of mycobacteruam bovis ( bcg )
- Paracoccidioides brasiliensis polysaccharide having granuloma-inducing toxic and macrophage - stimulating activity
- Role of cord factor in the modulation of infection caused by mycobacteria
- Participacao de glicolipideos na imunopatologia da infeccao por mycobacterium bovis (bcg)
- Imunizações gênicas
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas